Whitehawk Therapeutics, Inc. (WHWK) stock
WHWKNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.13+0.05 (+1.62%)
Close on Nov 18, 2026Market cap $178.44MP/E –Yield –
Whitehawk Therapeutics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Whitehawk Therapeutics's operating income for the twelve months ending Jun 30, 2026 was -$86.06M. For fiscal 2025 it was -$114.40M. The highest annual figure on record is -$20.51K in fiscal 2010.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$114.40M | – |
| FY2024 | Dec 31, 2024 | -$67.46M | – |
| FY2023 | Dec 31, 2023 | -$71.93M | – |
| FY2022 | Dec 31, 2022 | -$62.68M | – |
| FY2021 | Dec 31, 2021 | -$111.22M | – |
| FY2020 | Dec 31, 2020 | -$2.55M | – |
| FY2019 | Dec 31, 2019 | -$24.44M | – |
| FY2018 | Dec 31, 2018 | -$11.18M | – |
| FY2017 | Dec 31, 2017 | -$21.39M | – |
| FY2016 | Dec 31, 2016 | -$16.63M | – |
| FY2015 | Dec 31, 2015 | -$23.01K | – |
| FY2014 | Dec 31, 2014 | -$23.97K | – |
| FY2013 | Dec 31, 2013 | -$22.82K | – |
| FY2012 | Dec 31, 2012 | -$22.39K | – |
| FY2011 | Dec 31, 2011 | -$23.59K | – |
| FY2010 | Dec 31, 2010 | -$20.51K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$18.11M | – |
| Q1 FY2026 | Mar 31, 2026 | -$23.52M | – |
| Q4 FY2025 | Dec 31, 2025 | -$24.89M | – |
| Q3 FY2025 | Sep 30, 2025 | -$19.55M | – |
| Q2 FY2025 | Jun 30, 2025 | -$54.75M | – |
| Q1 FY2025 | Mar 31, 2025 | -$15.22M | – |
| Q4 FY2024 | Dec 31, 2024 | -$18.95M | – |
| Q3 FY2024 | Sep 30, 2024 | -$13.41M | – |
| Q2 FY2024 | Jun 30, 2024 | -$15.58M | – |
| Q1 FY2024 | Mar 31, 2024 | -$19.51M | – |
| Q4 FY2023 | Dec 31, 2023 | -$17.71M | – |
| Q3 FY2023 | Sep 30, 2023 | -$17.85M | – |
| Q2 FY2023 | Jun 30, 2023 | -$19.55M | – |
| Q1 FY2023 | Mar 31, 2023 | -$16.83M | – |
| Q4 FY2022 | Dec 31, 2022 | -$15.47M | – |
| Q3 FY2022 | Sep 30, 2022 | -$15.04M | – |
| Q2 FY2022 | Jun 30, 2022 | -$18.36M | – |
| Q1 FY2022 | Mar 31, 2022 | -$13.81M | – |
| Q4 FY2021 | Dec 31, 2021 | -$15.95M | -289.7% |
| Q3 FY2021 | Sep 30, 2021 | -$87.31M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.88M | -141.9% |
| Q1 FY2021 | Mar 31, 2021 | -$4.09M | – |
| Q4 FY2020 | Dec 31, 2020 | $8.40M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.66M | – |
| Q2 FY2020 | Jun 30, 2020 | $9.26M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.11M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.66M | – |
| Q3 FY2019 | Sep 30, 2019 | -$4.97M | -144.4% |
| Q2 FY2019 | Jun 30, 2019 | -$5.98M | – |
| Q1 FY2019 | Mar 31, 2019 | -$8.84M | – |
| Q4 FY2018 | Dec 31, 2018 | -$8.87M | – |
| Q3 FY2018 | Sep 30, 2018 | $11.20M | – |
| Q2 FY2018 | Jun 30, 2018 | -$6.04M | – |
| Q1 FY2018 | Mar 31, 2018 | -$7.48M | – |
| Q4 FY2017 | Dec 31, 2017 | -$6.29M | – |
| Q3 FY2017 | Sep 30, 2017 | -$4.76M | – |
| Q2 FY2017 | Jun 30, 2017 | -$5.58M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.76M | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.31M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.75M | – |
See a number that looks wrong?